A recent study showed that postmenopausal women who were prescribed estrogen therapy had a significantly lower risk for death after contracting COVID-19 compared with a control group. It was the top story in endocrinology last week.
The second top story evaluated the effects of switching generic levothyroxine preparations on hormone levels. Guidelines published by the American Thyroid Association advise providers to avoid switching generic levothyroxine products from different manufacturers, leading providers to prescribe brand-name levothyroxine for most adults with hypothyroidism, according